Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Allergy and Asthma Following Children Who Were Fed Supplemented Infant Formula
This study has been completed.
Sponsors and Collaborators: Mead Johnson
National Institutes of Health (NIH)
Information provided by: Mead Johnson
ClinicalTrials.gov Identifier: NCT00740974
  Purpose

Long-term cognitive outcome study of children who participated in randomized trials of LCP-supplemented formula during infancy.


Condition
Allergy
Asthma

MedlinePlus related topics: Allergy Asthma Infant and Toddler Nutrition
U.S. FDA Resources
Study Type: Observational

Further study details as provided by Mead Johnson:

Primary Outcome Measures:
  • Prevalence of asthma and allergy related diagnosis in medical records during first 3 years of life. [ Time Frame: after first 3 years of life ]

  Eligibility

Ages Eligible for Study:   up to 12 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Study Population

children previously randomized in a clinical study consuming LCP-supplemented infant formula

Criteria

Inclusion Criteria:

  • children previously randomized in a clinical study consuming LCP-supplemented infant formula

Exclusion Criteria:

  • children who did not previously participate in a randomized clinical study consuming LCP-supplemented infant formula
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00740974

Locations
United States, Texas
Retina Foundation of the Southwest
Dallas, Texas, United States, 75231
Sponsors and Collaborators
Mead Johnson
  More Information

Study ID Numbers: 8580
Study First Received: August 22, 2008
Last Updated: August 22, 2008
ClinicalTrials.gov Identifier: NCT00740974  
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Lung Diseases, Obstructive
Hypersensitivity
Respiratory Tract Diseases
Lung Diseases
Hypersensitivity, Immediate
Asthma
Respiratory Hypersensitivity

Additional relevant MeSH terms:
Immune System Diseases
Bronchial Diseases

ClinicalTrials.gov processed this record on January 16, 2009